GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,343
Funds Holding Change
+182
Funds Holding Growth
+8%
Value
$399B
Holding in Top 10
465
Top 10 Change
-1
Top 10 Growth
-0.2%
Value Growth
+5%
New
281
Increased
868
Reduced
1,043
Closed
74
Capital Inflow
$16B
Capital Outflow
$19.3B
Net Capital Flow
-$3.31B
Capital Flow Change
+$4.6B
Calls
$6.06B
Puts
$6.98B
Net Calls
-$918M
Put/Call Ratio
1.15